Resources from the same session
Antibody-drug conjugates: Current perspectives
Presenter: Antonio Passaro
Session: Daiichi Sankyo and AstraZeneca - Addressing the unmet need in mNSCLC: Treating progression after immunochemotherapy
Resources:
Webcast
Antibody-drug conjugates: Future considerations
Presenter: Enriqueta Felip
Session: Daiichi Sankyo and AstraZeneca - Addressing the unmet need in mNSCLC: Treating progression after immunochemotherapy
Resources:
Webcast